Development of surgical quality‐control mechanisms in large‐scale prospective trials: Head and neck intergroup report
Authors:
- 1 January 1991
- journal article
- clinical trial
- Published by Wiley in Head & Neck
- Vol. 13 (1) , 28-32
Abstract
One of the current national prospective clinical trials of the Head and Neck Intergroup explores the usage of chemotherapy in advanced operable head and neck cancer patients. The experimental arm consists of the addition of 3 courses of cisplatin‐containing chemotherapy to standard treatment defined as surgery followed by postoperative radiotherapy. In the design of the study it is necessary to define not only the extent of the surgery performed for each eligible lesion, but also to insure uniformity of surgery performed between surgeons and institutions. This will hopefully insure that any variation between the 2 arms of the study represent the effect of the chemotherapy. The procedure to obtain and confirm uniformity of surgery is multifaceted. It is, however, fundamentally based upon the current TNM staging system and therefore has intrinsic limitations.Keywords
This publication has 4 references indexed in Scilit:
- Combined radiation therapy and surgery in the management of advanced head and neck cancer: Final report of study 73–03 of the radiation therapy oncology groupHead & Neck Surgery, 1987
- The Impact of Surgical Quality Control in Multi-Institutional Group Trials Involving Adjuvant Cancer TreatmentsAnnals of Surgery, 1983
- Randomised Controlled Clinical Trials1983
- The Randomized Clinical TrialNew England Journal of Medicine, 1972